KRAS Tests Market Size, Share, Trends & Forecast

KRAS Tests Market is developing alongside the growing use of molecular diagnostics and precision oncology. KRAS testing helps identify genetic alterations that can provide clinically relevant information for cancer diagnosis, treatment planning, and patient stratification.

Colorectal and lung cancers are important areas for KRAS testing because specific KRAS mutations can influence treatment selection. Testing can help healthcare professionals determine whether patients may be appropriate for particular targeted therapies or other treatment strategies.

Polymerase chain reaction, next-generation sequencing, and other molecular diagnostic technologies are used to identify KRAS mutations. Improvements in testing sensitivity, turnaround time, and multiplex analysis are supporting broader use of molecular biomarkers in oncology.

Hospitals, clinical laboratories, diagnostic centers, pharmaceutical companies, and research institutions are important participants in the market. Continued development of precision medicine and companion diagnostics can create additional opportunities for KRAS testing technologies.

Read More
Lukoon https://lukoon.com